Literature DB >> 11473988

Detection of precytopathic effect of enteroviruses in clinical specimens by centrifugation-enhanced antigen detection.

S M Lipson1, K David, F Shaikh, L Qian.   

Abstract

Rapid enterovirus detection is important for decisions about antibiotic administration and length of hospital stay. The efficacy of rapid antigen detection-cell culture amplification (Ag-CCA) was evaluated with monoclonal antibodies (MAbs) 5-D8/1 (DAKO) and Pan-Enterovirus clone 2E11 (Chemicon) with 10 poliovirus, echovirus, and coxsackievirus type A and B stock isolates and College of American Pathologists check samples. By using Ag-CCA technology, MAb 2E11 was more sensitive than 5-D8/1 at detecting a greater number of stock isolates at or past tube (cytopathic effect [CPE]) culture (TC) end points. The efficacy of Ag-CCA in the clinical setting was subsequently confirmed with 273 consecutively freshly collected nasopharyngeal aspirate or swab specimens, rectal swab, and cerebrospinal fluid specimens during the 1999 enterovirus season. All specimens were tested by Ag-CCA in parallel with rhesus monkey kidney (RhMk), MRC-5, and A549 conventional TCs. Approximately 60% of field specimens were additionally tested with Hep-2 and HNK conventional TCs. Sixty-two percent of the clinical specimens tested were Ag-CCA positive after 48 h. Among 51 isolates, the mean time to CPE or culture confirmation was 5.5 days (range, 2 to 18 days). After 48 h, Ag-CCA achieved sensitivity, specificity, and positive and negative predictive values of 62, 100, 100, and 93%, respectively. During the same period, TC-CPE displayed test parameters of 12, 100, 100, and 85%, respectively. After 5 days, the sensitivity and specificity of Ag-CCA increased to 92 and 98%, respectively. Within the same period, isolation attained sensitivity and specificity of 52 and 100%, respectively. Although Ag-CCA displayed slightly reduced sensitivity and reduced specificity compared with conventional cell culture after 14 days, the markedly superior 48-h enterovirus Ag-CCA detection rate supports incorporation of this assay into the routine clinical setting.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473988      PMCID: PMC88235          DOI: 10.1128/JCM.39.8.2755-2759.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of a commercial DNA enzyme immunoassay for detection of enterovirus reverse transcription-PCR products amplified from cerebrospinal fluid specimens.

Authors:  P P Young; R S Buller; G A Storch
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies.

Authors:  S Yagi; D Schnurr; J Lin
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Detection of enteroviruses from clinical specimens by spin amplification shell vial culture and monoclonal antibody assay.

Authors:  S L Klespies; D E Cebula; C L Kelley; D Galehouse; C C Maurer
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

4.  Evaluation of an enterovirus group-specific anti-VP1 monoclonal antibody, 5-D8/1, in comparison with neutralization and PCR for rapid identification of enteroviruses in cell culture.

Authors:  A Trabelsi; F Grattard; M Nejmeddine; M Aouni; T Bourlet; B Pozzetto
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Laboratory diagnosis of respiratory virus infections in 24 hours by utilizing shell vial cultures.

Authors:  H D Engler; J Preuss
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

6.  Rapid shell vial culture technique for detection of enteroviruses and adenoviruses in fecal specimens: comparison with conventional virus isolation method.

Authors:  G J Van Doornum; J C De Jong
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

7.  Comparison of a rapid culture method combining an immunoperoxidase test and a group specific anti-VP1 monoclonal antibody with conventional virus isolation techniques for routine detection of enteroviruses in stools.

Authors:  T Bourlet; J Gharbi; S Omar; M Aouni; B Pozzetto
Journal:  J Med Virol       Date:  1998-03       Impact factor: 2.327

8.  Comparison of cell cultures for rapid isolation of enteroviruses.

Authors:  T Chonmaitree; C Ford; C Sanders; H L Lucia
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

  8 in total
  6 in total

1.  Engineered BGMK cells for sensitive and rapid detection of enteroviruses.

Authors:  Yung T Huang; Paul Yam; Huimin Yan; Yan Sun
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Rapid enterovirus RNA detection in clinical specimens by using nucleic acid sequence-based amplification.

Authors:  Marie L Landry; Robin Garner; David Ferguson
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Comparison of a reporter assay and immunomagnetic separation real-time reverse transcription-PCR for the detection of enteroviruses in seeded environmental water samples.

Authors:  Yu-Chen Hwang; Oymon M Leong; Wilfred Chen; Marylynn V Yates
Journal:  Appl Environ Microbiol       Date:  2007-02-02       Impact factor: 4.792

4.  Monoclonal antibodies to VP1 recognize a broad range of enteroviruses.

Authors:  Lynn Yihong Miao; Christina Pierce; Jennifer Gray-Johnson; Jill DeLotell; Carl Shaw; Nate Chapman; Elaine Yeh; David Schnurr; Yung T Huang
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

5.  Comparison of α-glucosyl hesperidin of citrus fruits and epigallocatechin gallate of green tea on the Loss of Rotavirus Infectivity in Cell Culture.

Authors:  Steven M Lipson; Fatma S Ozen; Samantha Louis; Laina Karthikeyan
Journal:  Front Microbiol       Date:  2015-04-29       Impact factor: 5.640

6.  Antiviral effects on bacteriophages and rotavirus by cranberry juice.

Authors:  S M Lipson; L Sethi; P Cohen; R E Gordon; I P Tan; A Burdowski; G Stotzky
Journal:  Phytomedicine       Date:  2006-11-29       Impact factor: 5.340

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.